Effect of Remote Intervention in Patients With SCAD

  • End date
    Apr 20, 2023
  • participants needed
  • sponsor
    Chinese Academy of Medical Sciences, Fuwai Hospital
Updated on 20 March 2021


The study was a multicenter, two-arm, parallel, open-label, prospective clinical trial that evaluated a remote intervention with 1 year of follow-up.


Objective: This study is intended to verify the effect of a remote intervention on adherence to drugs and risk factors control in patients with stable coronary artery disease.

Study design: The study was a multicenter, two-arm, parallel, open-label, prospective clinical trial that evaluated the effect of a remote intervention on adherence to drugs and risk factors control in patients with stable coronary artery disease with 1 year of follow-up.

Study intervention: Participants in the experimental group received remote guidance from the cardiac rehabilitation team in the community hospital every month after enrollment. The control group had no special intervention. All patients received follow-up at 6 months and 1-year follow-up.

Outcome measures: The primary outcome was medication adherence. Secondary outcomes included smoking, drinking, blood pressure, body mass index, LDL cholesterol, HbA1c, and major adverse cerebral cardiovascular events(MACCE). Medication compliance consists of the following five medications: aspirin, P2Y12 receptor antagonist, statin, ACEI/ARB and beta-blocker.

Statistical analysis: Values of analyzed endpoints between intervention group and control group will be compared according to the analysis plan. We'll follow a prespecified analysis plan and subgroup analysis will be conducted accordingly.

Condition Coronary Artery Disease, Coronary heart disease, Vascular Diseases, Heart disease, Cardiovascular Disease, Ischemic Heart Disease, Stable Angina, Stable Angina Pectoris, Cardiac Ischemia, Myocardial Ischemia, Cardiac Disease, Stable Chronic Angina, cardiac diseases, heart diseases, cardiac disorders, cardiac disorder, heart disorder
Treatment remote intervention, Routine outpatient follow-up
Clinical Study IdentifierNCT04795492
SponsorChinese Academy of Medical Sciences, Fuwai Hospital
Last Modified on20 March 2021


Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 99 yrs?
Gender: Male or Female
Do you have any of these conditions: Heart disease or Vascular Diseases or heart disorder or Coronary Artery Disease or Coronary heart disease or Cardiac Disease or Cardiovascular Disease...?
Do you have any of these conditions: heart diseases or Cardiac Ischemia or cardiac disorders or Cardiac Disease or Ischemic Heart Disease or Coronary heart disease or Vascular Diseases or...?
Aged between 18-99 years
Diagnosed with SCAD according to guidelines by coronary CTA or coronary angiography (including stable angina, ischemic cardiomyopathy, and the stable course after acute coronary syndrome)
Have sufficient Chinese language proficiency to reading, speaking and listening
Live with at least one caregiver or guardian in the household
Presence of stable hemodynamics without using vasopressor
Able to individually consent
Not participating in any other clinical trial

Exclusion Criteria

Unable to provide informed consent
Unable to be involved in clinical follow-up and treatment
Suffered comorbidity with a life expectancy of less than 1 year
Have contra-indication to cardiac rehabilitation
Acute coronary syndrome
History of noncompliance with medical therapy
Severe valvular disease or valvular disease likely to require surgery or percutaneous valve replacement during the trial
Planned major surgery necessitating interruption of antiplatelet therapy
Inability to comply with the protocol
Has any condition that, in the opinion of the investigator, would make participation not be in the best interest of the subject or that could prevent, limit or confound the protocol-specified assessments
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note